Study: Metabolic-associated fatty liver disease is increasing among U.S. adults

FHS
June 17, 2023
5:08 am

The percent of metabolic associated fatty liver disease (MAFLD), the leading global cause of liver disease, is increasing in U.S. adults, according to a study presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

The Biggest Psychedelic News Stories of the Week – July 28 | Psychedelic Spotlight

Psychedelic access continues to expand, with Minneapolis becoming another in the growing list of cities decriminalizing psychedelics or deprioritizing related arrests. More research is underway

July 28, 2023

CDC Addresses Rebound of Mycoplasma Pneumonia in Kids

In the fall of 2023, emergency department (ED)-related visits for Mycoplasma pneumoniae in children rebounded somewhat from a lull during the COVID-19 pandemic, but the

February 24, 2024

Global study reveals mismatch in COVID-19 treatment guidelines with WHO standards

Study assesses global discrepancies in COVID-19 management guidelines across WHO member states, revealing that many national guidelines do not fully align with WHO recommendations, especially

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.